Medical Management of Adult Transsexual Persons

Emily L. Knezevich, Pharm.D; Laura K. Viereck, Pharm.D; Andjela T. Drincic, M.D.

Disclosures

Pharmacotherapy. 2012;32(1):54-66. 

In This Article

Conclusion

With the increasing recognition of GID, pharmacists will likely encounter patients using hormone therapy to achieve sex characteristics of their identified gender. It is pertinent for pharmacists to be familiar with the standards of care that have been developed to optimize patient safety and outcomes. There are many therapeutic options for the treatment of GID, but they do not come without risks. The risks and benefits of therapy should be appropriately weighed and extensively discussed with each patient desiring cross-sex hormone therapy.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....